Officials with drugmaker Starpharma Holdings Ltd. say the company plans to release the first herpes-killing vaginal gel within the next two years. The gel, called VivaGel, is set to begin patient trials to see if it is effective at protecting women who are at risk for contracting genital herpes.
Read full story >